- Home
- MRK vs PRA Comparison
MRK vs PRA Comparison
Compare MRK & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | PRA |
|---|---|---|
| Founded | 2000 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 1.2B |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MRK | PRA |
|---|---|---|
| Price | $114.70 | $24.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 2 |
| Target Price | ★ $124.29 | $25.00 |
| AVG Volume (30 Days) | ★ 7.3M | 563.7K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | 0.99 |
| Revenue | ★ $65,011,000,000.00 | $1,098,028,000.00 |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $5.47 | N/A |
| P/E Ratio | ★ $15.72 | $24.74 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $22.72 |
| 52 Week High | $125.14 | $24.77 |
Technical Indicators
Market Signals| Indicator | MRK | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 47.70 |
| Support Level | $113.82 | $23.88 |
| Resistance Level | $125.14 | $24.64 |
| Average True Range (ATR) | 2.50 | 0.12 |
| MACD | -0.81 | -0.02 |
| Stochastic Oscillator | 13.38 | 12.86 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.